RMD vs WST
ResMed Inc. Common Stock · West Pharmaceutical Services, Inc. Common Stock
Relative return (rebased to 100)
Key stats
| Metric | RMD | WST |
|---|---|---|
| Price | $242.61 | $404.02 |
| Market Cap | $34.12B | $28.14B |
| P/E | 22.40 | 57.01 |
| P/B | 5.74 | 9.48 |
| P/S | 6.04 | 9.16 |
| ROE | 25.6% | 16.6% |
| Net Margin | 26.9% | 16.1% |
| Gross Margin | 61.1% | 35.9% |
| Revenue Growth | 9.9% | 6.3% |
| Dividend Yield | 0.99% | 0.21% |
| EPS | $10.83 | $7.09 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.